Context Capital Management, LLC - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 11 filers reported holding PDL BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Context Capital Management, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2020$1,149,000
-21.6%
465,1720.0%0.16%
-50.6%
Q3 2020$1,465,000
-28.1%
465,172
-33.6%
0.32%
-59.9%
Q2 2020$2,038,000
-12.0%
700,172
-1.9%
0.79%
-31.7%
Q4 2019$2,316,000–713,782–1.16%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders